QUICK LINKS
MAIN MENU
CONNECT WITH US

Button

Clinical Trial Details

Title
GS-US-417-0303: A Randomized, Double-blind, Placebo-and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severly Active Rheumatoid Arthritis Who Are Naïve to MTX Therapy
Study Description

The purpose of this study is to see if filgotinib can be useful to treat RA as single therapy or in combination with Methotrexate (MTX).

Investigators

Principal Investigator
Gurjit S. Kaeley, M.D.
Medicine

Sub Investigator
Karishma Ramsubeik, M.B.B.S. (M.D.)
Medicine

Sub Investigator
Myint Thway, M.D.
Medicine

Resources

News & Announcements

Upcoming Events

Apr 14